We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Discovering Key Genes To Build a Better Cancer Drug

News   Apr 29, 2020 | Original story from Washington State University

 
Discovering Key Genes To Build a Better Cancer Drug

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Oxford's COVID-19 Vaccine Has 70% Efficacy Rate

News

There are now over 170 teams of researchers working to develop a vaccine for protection against COVID-19. Over the last few weeks, a number of groups shared interim analysis data on candidates that have reached Phase III clinical testing. The latest addition is the University of Oxford – in collaboration with the pharmaceutical company AstraZeneca – who today announce an efficacy of 70.4% for the candidate, ChAdOx1 nCoV-2019.

READ MORE

Ovarian Cancer Cells Cooperate To Metastasize

News

Any given tumor is composed of a multitude of cell types that can each look or behave differently from its neighbors. A new study shows that this cell diversity can also play a vital role in cancer's ability to invade distant sites within the body.

READ MORE

Metal-Organic Frameworks Successfully Deliver CRISPR/Cas9 Into Human Cancer Cells

News

Researchers used metal-organic frameworks (MOFs) enhanced with a green tea phytochemical coating to target human prostate cancer cells for the first time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE